Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $3.54 Million - $4.79 Million
-41,500 Reduced 67.59%
19,900 $211 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $3.48 Million - $5.22 Million
50,000 Added 438.6%
61,400 $469 Million
Q3 2023

Nov 09, 2023

BUY
$96.41 - $126.61 $125,333 - $164,593
1,300 Added 12.87%
11,400 $1.18 Million
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $1.2 Million - $1.62 Million
10,100 New
10,100 $1.23 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $1.18 Million - $2.1 Million
10,000 Added 48.31%
30,700 $159,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $141,684 - $233,016
1,200 Added 6.15%
20,700 $413,000
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $5.21 Million - $7.86 Million
-44,500 Reduced 69.53%
19,500 $457,000
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $2.95 Million - $5.48 Million
-23,300 Reduced 26.69%
64,000 $2.81 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $225,820 - $368,510
-1,000 Reduced 1.13%
87,300 $2.21 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $1.44 Million - $3.15 Million
6,500 Added 7.95%
88,300 $1.74 Million
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $870,397 - $1.57 Million
6,700 Added 8.92%
81,800 $103,000
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $196,524 - $334,764
-1,800 Reduced 2.34%
75,100 $724,000
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.51 Million - $3.91 Million
23,000 Added 42.67%
76,900 $917,000
Q3 2020

Nov 13, 2020

SELL
$54.34 - $94.85 $1.52 Million - $2.66 Million
-28,000 Reduced 34.19%
53,900 $224,000
Q2 2020

Aug 10, 2020

BUY
$29.67 - $80.0 $2.06 Million - $5.56 Million
69,500 Added 560.48%
81,900 $161,000
Q1 2020

May 08, 2020

BUY
$17.78 - $31.58 $220,472 - $391,592
12,400 New
12,400 $40,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.